| Stage | AR | % of rev | CRC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $1.3B | 100.00% | AR ×1.20 |
| Gross profit | $780M | 49.92% | $1.2B | 95.76% | CRC +45.8pp |
| Operating income | $392M | 25.07% | $511M | 39.40% | CRC +14.3pp |
| Pre-tax income | $464M | 29.66% | $458M | 35.31% | CRC +5.7pp |
| Net income | $367M | 23.49% | $514M | 39.63% | CRC +16.1pp |
| Stage | AR | CRC | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $1.3B100.00% | AR ×1.20 |
| Gross profit | 49.92%$780M | 95.76%$1.2B | CRC +45.8pp |
| Operating income | 25.07%$392M | 39.40%$511M | CRC +14.3pp |
| Pre-tax income | 29.66%$464M | 35.31%$458M | CRC +5.7pp |
| Net income |
| 23.49%$367M |
| 39.63%$514M |
| CRC +16.1pp |
No disclosed counterparties: CRC.
None